Next generation bisulfite sequencing
Cambridge Epigenetix Funding
$21M
11 round
Cambridge Epigenetix is active in the following markets / industries: biotechnology, health care, hospitals and clinical trials. The company has secured funding across 1 rounds, totaling in an amount of $21M. Their most recent funding was raised on May 14, 2016.
Funding Rounds
Investors of Cambridge Epigenetix
University of Cambridge Enterprise
We help the daring build legendary companies
Rounds
B
New Science Ventures
Rounds
B
Cambridge Enterprise
Rounds
B